Medication alternatives · FDA-sourced
Breo Ellipta Alternatives and Authorized Generic Options
FDA lists authorized-generic fluticasone furoate/vilanterol inhalation powder for the Breo Ellipta 100/25 mcg and 200/25 mcg strengths. Advair Diskus and Symbicort are separate ICS/LABA treatment alternatives with different ingredients, strengths, devices, or dosing schedules; they are not dose-equivalent substitutes for Breo Ellipta.
Authorized Generic
Matching Breo Ellipta and authorized-generic strengths
FDA lists fluticasone furoate/vilanterol inhalation powder as an authorized generic for the matching 100/25 mcg and 200/25 mcg Breo Ellipta products. An authorized generic is the same NDA drug product marketed without the brand name; it is distinct from a conventional ANDA generic.
Breo Ellipta
100/25 mcg — 1 inhalation once daily
Fluticasone Furoate/Vilanterol ELLIPTA
100/25 mcg — 1 inhalation once daily
Breo Ellipta
200/25 mcg — 1 inhalation once daily
Fluticasone Furoate/Vilanterol ELLIPTA
200/25 mcg — 1 inhalation once daily
Why 50/25 mcg is not shown: the FDA authorized-generics listing used for this page identifies 100/25 mcg and 200/25 mcg. It does not identify a 50/25 mcg authorized-generic product.
Same-Class Alternatives
Other ICS/LABA maintenance inhalers
Advair Diskus and Symbicort share the ICS/LABA class and have labeled asthma and COPD uses, but they are different products. These comparisons do not establish dose equivalence, automatic substitution, or a recommended switch.
Same-Class Option
Advair Diskus
Fluticasone Propionate/Salmeterol
- Class
- ICS/LABA
- Device
- Dry Powder Inhaler
Breo Ellipta and Advair Diskus are ICS/LABA dry-powder inhalers with labeled asthma and COPD maintenance uses. They contain different corticosteroids and LABAs and use different dosing schedules.
Breo Ellipta contains fluticasone furoate/vilanterol and is administered once daily. Advair Diskus contains fluticasone propionate/salmeterol and is administered twice daily. Their labeled microgram strengths are not interchangeable or comparable mcg-for-mcg.
This is a same-class treatment alternative, not an FDA therapeutic-equivalence or dose-conversion relationship. Do not switch products or strengths without prescriber or pharmacist guidance.
Same-Class Option
Symbicort
Budesonide/Formoterol
- Class
- ICS/LABA
- Device
- Metered Dose Inhaler
Breo Ellipta and Symbicort are ICS/LABA maintenance inhalers with labeled asthma and COPD uses. They contain different active ingredients and differ in device and dosing schedule.
Breo Ellipta is a once-daily dry-powder inhaler containing fluticasone furoate/vilanterol. Symbicort is a twice-daily metered-dose inhaler containing budesonide/formoterol. Their labeled strengths are not dose equivalents.
This is a same-class treatment alternative, not an FDA therapeutic-equivalence or dose-conversion relationship. Do not switch products or strengths without prescriber or pharmacist guidance.
Equivalent and alternative are different
Only the matching fluticasone furoate/vilanterol authorized-generic products are displayed as direct matches. Advair Diskus and Symbicort differ in ingredients and schedule, and Symbicort also uses a different inhaler type.
Device and schedule still matter
Breo Ellipta is taken once daily through a dry-powder inhaler. Other ICS/LABA options may be taken twice daily or use a metered-dose device. A clinician or pharmacist should confirm the prescribed strength and teach the correct technique.
Common Questions
Breo Ellipta alternatives and generic FAQ
Does Breo Ellipta have a generic?
FDA lists authorized-generic fluticasone furoate/vilanterol inhalation powder for the Breo Ellipta 100/25 mcg and 200/25 mcg strengths. An authorized generic is the same drug product marketed under the brand product NDA without the brand name; it is different from a conventional generic approved through an ANDA.
Which Breo Ellipta strengths have an authorized generic?
The FDA authorized-generics listing used for this page identifies the 100/25 mcg and 200/25 mcg inhalation-powder strengths. This page does not present the 50/25 mcg strength as an authorized-generic match because that strength is not identified in the listing.
Is Advair Diskus equivalent to Breo Ellipta?
No. Both are ICS/LABA dry-powder maintenance inhalers, but Breo Ellipta contains fluticasone furoate/vilanterol and is taken once daily, while Advair Diskus contains fluticasone propionate/salmeterol and is taken twice daily. Advair is shown as a same-class alternative, not as a dose-equivalent substitute.
Is Symbicort equivalent to Breo Ellipta?
No. Both are ICS/LABA maintenance inhalers, but Breo Ellipta is a once-daily dry-powder inhaler containing fluticasone furoate/vilanterol. Symbicort is a twice-daily metered-dose inhaler containing budesonide/formoterol. Their strengths are not dose equivalents.
Which Breo Ellipta alternatives are once daily?
Breo Ellipta and its matching authorized-generic fluticasone furoate/vilanterol products are labeled for once-daily use. Advair Diskus and Symbicort are labeled for twice-daily use. Frequency is only one consideration; ingredients, strength, device technique, indication, age, and patient-specific factors also differ.
Can I switch from Breo Ellipta to another inhaler on my own?
No. Even when products share the ICS/LABA class, their ingredients, labeled strengths, devices, schedules, and approved populations may differ. A prescriber or pharmacist should confirm the product, strength, indication, coverage, and device technique before a switch.
Primary Sources
Evidence used for this page
DailyMed / U.S. National Library of Medicine
ADVAIR DISKUS Prescribing Information
Supports Advair Diskus ingredients, strengths, dry-powder device, twice-daily schedule, and labeled asthma and COPD uses.
DailyMed / U.S. National Library of Medicine
BREO ELLIPTA Prescribing Information
Supports Breo Ellipta ingredients, strengths, device, dosing schedule, indications, populations, and limitations.
DailyMed / U.S. National Library of Medicine
Fluticasone Furoate/Vilanterol ELLIPTA Prescribing Information
Supports the unbranded fluticasone furoate/vilanterol product ingredients, strengths, device, dosing schedule, indications, populations, and limitations.
DailyMed / U.S. National Library of Medicine
SYMBICORT Prescribing Information
Supports Symbicort ingredients, strengths, metered-dose device, twice-daily schedule, and labeled asthma and COPD uses.
U.S. Food and Drug Administration
FDA List of Authorized Generic Drugs
Explains the FDA definition and therapeutic-equivalence status of authorized generics.
U.S. Food and Drug Administration
FDA Listing of Authorized Generics
Identifies BREO ELLIPTA inhalation powder 100/25 mcg and 200/25 mcg in the FDA authorized-generics listing.
Reviewed by PulmTools Editorial Review on August 28, 2026.
Explore respiratory pharmacology →